Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients-Reference-Cited by-同舟云学术

Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients

Published:2018-03 Issue: Volume:129 Page:84-94
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Marquet Pierre,Albano Laetitia,Woillard Jean-Baptiste,Rostaing Lionel,Kamar Nassim,Sakarovitch Charlotte,Gatault Philippe,Buchler Matthias,Charpentier Bernard,Thervet Eric,Cassuto Elisabeth

Publisher

Elsevier BV

Subject

Pharmacology

Reference26 articles.

1. Advagraf®, a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts;Caillard;Transpl. Int.,2016

2. Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial;Wlodarczyk;Am. J. Transplant.,2009

3. Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation;Niioka;Transplantation,2012

4. Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation;de Jonge;Transplantation,2010

5. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure;Saint-Marcoux;Ther. Drug Monit.,2013

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring of tacrolimus after kidney transplantation: trough concentration or area under curve‐based monitoring?;British Journal of Clinical Pharmacology;2024-06-06

2. Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort;Clinical Pharmacology in Drug Development;2024-01-04

3. Machine Learning Models for Predicting Personalized Tacrolimus Stable Dosages in Pediatric Renal Transplant Patients;BioMedInformatics;2023-10-14

4. Volumetric Absorptive Microsampling to Enhance the Therapeutic Drug Monitoring of Tacrolimus and Mycophenolic Acid: A Systematic Review and Critical Assessment;Therapeutic Drug Monitoring;2023-01-02

5. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients;British Journal of Clinical Pharmacology;2022-11-06